The UK is to offer under 30s alternatives to the Oxford/AstraZeneca COVID-19 vaccine after confirming a small increased risk of serious thrombotic events, it was announced last night.
It came as regulators reported a significant increase in reports of thrombotic events that have followed vaccination – although the absolute risk of anyone experiencing these clots is extremely rare.
All the events were associated with low platelet counts, the Medicines and Healthcare products Regulatory Agency (MHRA) said.
It found 79 cases of thrombosis of low platelet counts including 19 deaths. These include 44 cases of cerebral venous sinus thrombosis (CVST) and 35 cases of thrombosis in other major veins. The numbers represent four...
4 days ago
The UK is to offer under 30s alternatives to the Oxford/AstraZeneca COVID-19 vaccine after confirming a small increased risk of serious thrombotic events, it was announced last night.
It came as regulators reported a significan...
4 days ago
Scientists have reported new information about how anti-CD20 antibodies trigger the immune system to attack tumour cells.
Anti-CD20 antibodies, such as rituximab, are used in clinical practice to treat patients with B-cell lymp...
4 days ago